Medtronic MiniMed, Inc.: CareLink Clinic, REF: MMT-7350
- Recall status
- Ongoing (still active)
- Severity
- Class II: could cause temporary or reversible health problems What recall classes mean
- Where sold
- US Nationwide distribution in the state of KS.
Common questions
- Is Medtronic MiniMed CareLink Clinic REF: MMT-7350 recalled?
- Yes. FDA (device) recalled Medtronic MiniMed CareLink Clinic REF: MMT-7350 on 2026-10-28. Recall status: Ongoing (still active).
- What is the hazard?
- CareLink Clinic software version 4.4A includes a software defect in the Settings Calculator feature in which the calculation logic fails to use custom values entered by healthcare professionals (HCPs) for Total Daily Dose (TDD) or Long-acting insulin when calculating the Carb Ratio, Insulin Sensitivity Factor (ISF)...
- Where was it sold?
- US Nationwide distribution in the state of KS.
Read the official notice at FDA (device) →
Is Medtronic MiniMed recalled?
More recalls
- Medtronic MiniMed, Inc.: Generic Name: MiniMed Go App Generic Name: MiniMed Go
- Medtronic MiniMed, Inc.: Brand Name: MiniMed Flex Product Name: MiniMed Flex
- Medtronic MiniMed, Inc.: MiniMed 780G Insulin Pump, Model: MMT-1885CLW
- Medtronic MiniMed, Inc.: MiniMed 670G Insulin Pump, Model: MMT-1781, MMT-1782;
- Medtronic MiniMed, Inc.: MiniMed 640G Insulin Pump, Model: MMT-1711, MMT-1712;
The text below is copied from the official FDA (device) record. If anything differs, the official notice is correct.
- Company / brand
- Medtronic MiniMed, Inc.
- Product
- CareLink Clinic, REF: MMT-7350
- Reason / hazard
- CareLink Clinic software version 4.4A includes a software defect in the Settings Calculator feature in which the calculation logic fails to use custom values entered by healthcare professionals (HCPs) for Total Daily Dose (TDD) or Long-acting insulin when calculating the Carb Ratio, Insulin Sensitivity Factor (ISF), and Max Recommended value for Rapid-acting insulin. Instead, the calculator continues to use the system-recommended values, resulting in incorrect rapid-acting insulin parameters. If an HCP or patient inputs these incorrect setting values into the patient's MiniMed Go app, the patient could deliver higher or lower insulin doses compared to their insulin needs, potentially leading to over/under delivery of insulin with a severity ranging from Catastrophic (death from severe hypoglycemia) to Minor (self-treatable hypoglycemia/hyperglycemia).
- What to do (remedy)
- Classification
- Class II
- Status
- Ongoing
- Distribution / sold at
- US Nationwide distribution in the state of KS.
- Recall initiated
- 2026-09-11
- Code info
- UDI-DI: 0763000B00008748K. Software Versions: 4.4A Software Available: US: Between June 4th, 2026, and June 8th, 2026.
- Product quantity
- 1
- Voluntary mandated
- Voluntary: Firm initiated
- City
- Northridge
- State
- CA
- Country
- United States
- Event id
- 99765
Free daily digest + "My products" watchlist